Piha-Paul, Sarina A <br/><br/>
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies.  [electronic resource] 

 -  International journal of cancer  10 2020 
 - 2190-2198 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.33013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>B7-H1 Antigen--metabolism<br/>Biliary Tract Neoplasms--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Response Evaluation Criteria in Solid Tumors